SiGnal-DSarcopenia and Pregnancy Outcomes in Gestational Diabetes

This study explores the presence of sarcopenia, a condition where people lose muscle mass and strength, in women with gestational diabetes (GDM). Sarcopenia is not only a concern for older adults but can also affect younger individuals, including women of childbearing age. Researchers are investigating whether women with GDM are more likely to experience sarcopenia and how it might influence pregnancy outcomes and mental functions. Understanding these connections could help improve health strategies for pregnant women, potentially preventing complications and reducing the risk of developing type 2 diabetes in the future. Participants in this study will undergo a test called the oral glucose tolerance test (OGTT) to assess their body's glucose processing ability, focusing on insulin resistance, a known risk factor for sarcopenia. Clinical data relevant to sarcopenia will be collected to see if there is a link between this condition and GDM. By comparing women with and without GDM, researchers aim to determine how common sarcopenia is among these groups. This information could guide future interventions to prevent sarcopenia and improve pregnancy outcomes.